{"id": "1375780187804172289", "creation": 1616846532.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "quoted": "1375773377965785089", "text": "\u201cThe launch in #India of a new #COVID19 #vaccine developed jointly by the @SerumInstIndia and U.S.-based biotech firm @Novavax is likely to be delayed to September, [Adar Poonawalla, the chief executive of SII] said...\u201d \ud83e\udd14 #procurement #supplychains https://t.co/oTqZzCjo84", "first_save": 1634559108.199414, "hashtags": ["#INDIA", "#COVID19", "#VACCINE", "#PROCUREMENT", "#SUPPLYCHAINS"]}